$ACHV
ACHIEVE LIFE SCIENCES, INC.

2021 Q3 Form 10-Q Financial Statement

#000156459021055729 Filed on November 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.102M $1.860M $1.820M
YoY Change 13.01% -1.59% 11.66%
% of Gross Profit
Research & Development $4.591M $1.891M $1.103M
YoY Change 142.78% 3.67% -45.72%
% of Gross Profit
Depreciation & Amortization $61.00K $60.00K $70.00K
YoY Change 1.67% 0.0% 16.67%
% of Gross Profit
Operating Expenses $6.693M $1.891M $1.103M
YoY Change 253.94% 3.67% -45.72%
Operating Profit
YoY Change
Interest Expense $3.000K $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$1.000K -$10.00K -$4.000K
YoY Change -90.0% -122.73% -110.53%
Pretax Income -$6.691M -$3.760M -$2.920M
YoY Change 77.95% 2.45% -19.34%
Income Tax
% Of Pretax Income
Net Earnings -$6.691M -$3.764M -$2.922M
YoY Change 77.76% 2.48% -19.37%
Net Earnings / Revenue
Basic Earnings Per Share -$0.71
Diluted Earnings Per Share -$707.9K -$1.143M -$1.678M
COMMON SHARES
Basic Shares Outstanding 9.452M
Diluted Shares Outstanding 9.452M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.31M $22.40M $12.10M
YoY Change 48.71% 202.7% 16.35%
Cash & Equivalents $33.30M $22.44M $12.10M
Short-Term Investments
Other Short-Term Assets $1.270M $1.700M $500.0K
YoY Change -25.29% 466.67% 25.0%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $34.73M $24.10M $12.70M
YoY Change 44.12% 215.49% 17.57%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $50.00K $300.0K
YoY Change 100.0% -21.88% 322.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $235.0K $400.0K $500.0K
YoY Change -41.25% 110.53% 170.27%
Total Long-Term Assets $3.066M $3.500M $3.800M
YoY Change -12.4% -9.16% -3.87%
TOTAL ASSETS
Total Short-Term Assets $34.73M $24.10M $12.70M
Total Long-Term Assets $3.066M $3.500M $3.800M
Total Assets $37.80M $27.60M $16.50M
YoY Change 36.95% 140.17% 11.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $815.0K $300.0K $500.0K
YoY Change 171.67% -47.74% -29.28%
Accrued Expenses $2.261M $1.500M $1.300M
YoY Change 50.73% -42.31% -43.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.076M $1.800M $1.800M
YoY Change 70.89% -42.66% -39.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $23.00K $100.0K $100.0K
YoY Change -77.0% -50.0% -66.67%
Total Long-Term Liabilities $23.00K $100.0K $100.0K
YoY Change -77.0% -50.0% -66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.076M $1.800M $1.800M
Total Long-Term Liabilities $23.00K $100.0K $100.0K
Total Liabilities $3.099M $1.900M $1.900M
YoY Change 63.11% -44.12% -41.56%
SHAREHOLDERS EQUITY
Retained Earnings -$86.40M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.70M $25.68M $14.54M
YoY Change
Total Liabilities & Shareholders Equity $37.80M $27.60M $16.50M
YoY Change 36.95% 140.17% 11.83%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$6.691M -$3.764M -$2.922M
YoY Change 77.76% 2.48% -19.37%
Depreciation, Depletion And Amortization $61.00K $60.00K $70.00K
YoY Change 1.67% 0.0% 16.67%
Cash From Operating Activities -$8.694M -$4.330M -$2.200M
YoY Change 100.79% 41.04% -42.71%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$10.00K -$10.00K
YoY Change -100.0% -100.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.000K 14.62M 2.170M
YoY Change -99.95% -53.03%
NET CHANGE
Cash From Operating Activities -8.694M -4.330M -2.200M
Cash From Investing Activities 0.000 -10.00K -10.00K
Cash From Financing Activities 8.000K 14.62M 2.170M
Net Change In Cash -8.686M 10.28M -40.00K
YoY Change -184.49% -434.85% -101.28%
FREE CASH FLOW
Cash From Operating Activities -$8.694M -$4.330M -$2.200M
Capital Expenditures $0.00 -$10.00K -$10.00K
Free Cash Flow -$8.694M -$4.320M -$2.190M
YoY Change 101.25% 40.72% -42.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M23D
CY2020Q4 achv Other Assets And Restricted Cash
OtherAssetsAndRestrictedCash
237000
achv Shares Issued As Settlement With Trade Vendor As Non Monetary Transaction
SharesIssuedAsSettlementWithTradeVendorAsNonMonetaryTransaction
41000
achv Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
151000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
37286000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33300000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2922000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
14538000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
281000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2541000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5729000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33362000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22443000
CY2020Q3 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
2491000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3764000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
25675000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86400000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
542000
CY2021Q1 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
236000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7999000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
30088000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
621000
CY2021Q2 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
95000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11311000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40854000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
530000
CY2021Q3 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
8000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6691000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
18050000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
302000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3320000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
14985000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
308000
CY2020Q2 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
589000
us-gaap Net Income Loss
NetIncomeLoss
-26000000.0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24200000
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
236
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
236
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
231
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
231
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
227442
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
294650
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
39204.00
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
522090
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.11
us-gaap Share Based Compensation
ShareBasedCompensation
1693000
us-gaap Share Based Compensation
ShareBasedCompensation
891000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0064
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0143
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0961
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0464
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
530000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
281000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3600000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1818996
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1818996
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1397119
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1397119
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
91000
CY2021Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
68000
CY2021Q3 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
23000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
15000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
47000
us-gaap Operating Lease Payments
OperatingLeasePayments
68000
us-gaap Operating Lease Payments
OperatingLeasePayments
137000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M29D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M29D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.099
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.099
CY2021Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
achv Indemnification Expense
IndemnificationExpense
0

Files In Submission

Name View Source Status
0001564590-21-055729-index-headers.html Edgar Link pending
0001564590-21-055729-index.html Edgar Link pending
0001564590-21-055729.txt Edgar Link pending
0001564590-21-055729-xbrl.zip Edgar Link pending
achv-10q_20210930.htm Edgar Link pending
achv-10q_20210930_htm.xml Edgar Link completed
achv-20210930.xsd Edgar Link pending
achv-20210930_cal.xml Edgar Link unprocessable
achv-20210930_def.xml Edgar Link unprocessable
achv-20210930_lab.xml Edgar Link unprocessable
achv-20210930_pre.xml Edgar Link unprocessable
achv-ex311_6.htm Edgar Link pending
achv-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending